摘要
Nenad STANKOVIC 医师
牙科医师
Changing the paradigm in management of atrophic post-acne scarring with injectable skin boosters
Objectives: Learning outcomes for the abstract on skin-boosters in APAS treatment:
Understand the definition and prevalence of APAS.
Identify the challenges of treating APAS with traditional methods.
Describe the mechanism of action of skin-boosters in APAS.
Summarize the clinical evidence supporting the use of skin-boosters in APAS.
Discuss the safety and efficacy of skin-boosters in APAS.
Identify the different types of APAS that can be treated with skin-boosters.
Explain the compatibility of skin-boosters with other treatments for APAS.
Introduction: Atrophic post-acne scarring (APAS) is the most common type of acne scarring, affecting an estimated 85% of individuals with acne. APAS is a significant source of distress for patients, and traditional treatments have been challenging and often unsatisfactory.
Materials / method: Skin-boosters with stabilized, non-cross-linked HA, combined with amino acids and vitamines.
Intradermal inections in patients with APAS.
Results: Clinical studies have shown that skin-boosters are effective in reducing the appearance of APAS. Our study found that a series of three treatments with skin-boosters resulted in a significant improvement in the appearance of APAS in 80% of patients and that skin-boosters were more comfortable in reducing the appearance of APAS than traditional treatments, such as dermabrasion and chemical peels.
Conclusion: The use of skin-boosters in the treatment of APAS represents a paradigm shift. Skin-boosters are a promising new treatment for atrophic post-acne scarring. They are minimally invasive, safe, and effective with minimal downtime and side effects. Skin-boosters can be used to treat all types of APAS and can be combined with other treatments for APAS to achieve optimal results.
披露 - Nenad STANKOVIC
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2024年 3月 22日 - Recorded during IMCAS World Congress 2024